Key takeaways
Reyvow (lasmiditan) and Maxalt (rizatriptan) are both used to treat migraines, but they have some key differences. Reyvow (lasmiditan) is a serotonin agonist, while Maxalt (rizatriptan) is a triptan. Reyvow (lasmiditan) is only available as a brand-name medication, making it more expensive, whereas Maxalt (rizatriptan) is available in a lower-cost generic form. Reyvow (lasmiditan) is a controlled substance due to its potential for abuse, but Maxalt (rizatriptan) is not. Reyvow (lasmiditan) can cause significant dizziness and sleepiness, requiring you to avoid driving for at least 8 hours after taking it. Maxalt (rizatriptan) can also cause drowsiness but typically works faster, within 30 minutes. Additionally, Maxalt (rizatriptan) can be used by children ages 6 and older, while Reyvow (lasmiditan) is only approved for adults.
